Pregnancy: Studies in pregnant women have not shown that Iberet-Folic 500 increases the risk of fetal abnormalities if administered during pregnancy. If this drug is used during pregnancy, the possibility of fetal harm appears remote. Because studies cannot rule out of the possibility of harm, however, Iberet-Folic 500 should be used during pregnancy only if clearly needed.
Lactation: Folic acid, ascorbic acid, and B-complex vitamins are excreted in breast milk.
Other Services
Country
Account